CSS LLC/IL - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 40 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
CSS LLC/IL ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$76,000
+52.0%
45,219
+80.0%
0.00%
+100.0%
Q2 2022$50,000
-79.3%
25,119
-72.7%
0.00%
-77.8%
Q1 2022$242,000
+11.0%
92,019
+16.7%
0.01%
+12.5%
Q4 2021$218,000
+275.9%
78,861
+429.3%
0.01%
+300.0%
Q3 2021$58,000
-40.2%
14,9000.0%0.00%
-50.0%
Q2 2021$97,000
-21.1%
14,9000.0%0.00%
-20.0%
Q1 2021$123,000
+2.5%
14,900
+44.7%
0.01%
+25.0%
Q4 2020$120,00010,3000.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,518,371$9,746,0001.82%
Altium Capital Management LP 785,341$3,039,0000.80%
Ikarian Capital, LLC 2,691,110$10,415,0000.73%
Telemetry Investments, L.L.C. 130,500$505,0000.68%
Psagot Value Holdings Ltd. 143,591$556,0000.10%
Psagot Value Holdings Ltd. / (Israel) 143,591$556,0000.10%
ACT CAPITAL MANAGEMENT, LLC 28,500$110,0000.06%
X-Square Capital, LLC 17,973$70,0000.04%
GSA CAPITAL PARTNERS LLP 85,993$333,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 268,301$1,038,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders